NovalGen
Company Management

NovalGen

Biotechnology United Kingdom 14 employees
Employees
14
Contacts
3
Emails
2
Phones
2
novalgen.com LinkedIn

NovalGen Overview

Headquarters
United Kingdom
Phone Number
Available in AeroLeads
Website
novalgen.com
Industry
Biotechnology
Employees
14
Founded
2019
Company Email
Available in AeroLeads

About NovalGen

NovalGen is an innovative immuno-oncology company developing breakthrough bispecific therapies that can safely harness the immune system to fight cancer. NovalGen is focused on the development of cutting-edge, proprietary treatments for patients with hematologic malignancies and solid tumors by developing therapeutics that treat cancer using our breakthrough technologies in Bispecific antibodies and beyond

NovalGen Contact Details

People in AeroLeads
4
With contact data
3
Email contacts
2
50.0% coverage
Phone contacts
2
50.0% coverage

NovalGen Org Chart

Sample employees and titles
Name Title Contact
John-Paul Bukowski Bispecific Antibody R&D
Phone
David Granger Vice President, R&D at Novalgen
View
Mittal Shah Translational Scientist
Email
Vincent Muczynski Translational Scientist - Director
Email Phone

Employees by Management Level

Individual contributor 3 profiles
Associate / junior 2 profiles
Executive 1 profile
Director 1 profile

Department Contact Coverage

Department Contacts Email Phone
Executive 1 1 1
Sales 1 1 0
General 1 0 1

NovalGen Tech Stack

Data / AI 2 profiles
Engineering 1 profile

Compare Similar Companies to NovalGen

Spur Therapeutics
Biotechnology Research
Quell Therapeutics
Biotechnology Research
AAVantgarde
Biotechnology Research
Laverock Therapeutics
Biotechnology Research
Epsilogen Ltd
Biotechnology
Tizona Therapeutics, Inc.
Biotechnology Research
Ambagon Therapeutics
Biotechnology Research
Trishula Therapeutics, Inc.
Biotechnology Research
Kolibri
Biotechnology
Resalis Therapeutics
Biotechnology Research